Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
11-deoxycortisol + NADH + H+
? + NAD+
11alpha-hemisuccinyloxyprogesterone + NADH
?
-
-
-
-
?
17-hydroxy-3,11,20-trioxo-4-pregnen-21-oate + NADH
17,20-dihydroxy-3,11-dioxo-4-pregnen-21-oate + NAD+
-
-
-
-
?
17-hydroxy-3,20-dioxo-4-pregnen-21-oate + NADH
17,20-dihydroxy-4-pregnen-3-one-21-oate + NAD+
-
-
-
-
?
17-hydroxyprogesterone + NADH
?
-
-
-
-
?
17-hydroxyprogesterone + NADPH
17,20-beta-dihydroxy-4-pregnene-3-one
-
-
-
-
?
17alpha,20beta-dihydroxypregn-4-ene-3-one + NADP+
17alpha-hydroxypregn-4-en-3,20-dione + NADPH
-
-
-
-
?
17alpha-hydroxy-3,20-dioxo-4-pregnen-21-oate + NADH
17,20alpha-dihydroxy-4-pregnen-3-one-21-oate + NAD+
17alpha-hydroxypregnenolone + NADPH
3beta,17alpha,20beta-trihydroxypregn-5-ene + NADP+
-
i.e. 3beta,17alpha-dihydroxypregn-5-ene-20-one
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
17beta-estradiol + NAD+
estrone + NADH + H+
17beta-hydroxyandrostan-2-one + NADH + H+
?
-
-
-
-
r
17beta-[(1S)-1-hydroxy-2-propynyl]-androst-4-ene-3-one + NAD+
17beta-[1-oxo-2-propynyl]-androst-4-ene-3-one + NADH
-
-
-
?
20alpha-hydroxyprogesterone + NAD+
? + NADH
20beta-hydroxycortisone + NADH + H+
cortisone + NADH + H+
20beta-hydroxypregn-4-ene-3-one + NADP+
pregn-4-ene-3,20-dione + NADPH
-
-
-
-
?
20beta-hydroxyprogesterone + NAD+
? + NADH
21-acetoxyprogesterone + NADH
?
-
-
-
-
?
21-hemisuccinyloxyprogesterone + NADH
?
-
-
-
-
?
3,20-dioxo-4-pregnen-21-oic acid + NADH
20beta-hydroxy-3-oxo-4-pregnen-21-oic acid + NAD+
3alpha,20beta-hydroxysteroid androstanes or pregnane derivatives + NAD(P)H
?
3beta,17alpha,20alpha-trihydroxypregn-5-ene + NADP+
3beta,17alpha-dihydroxypregn-5-en-20-one + NADPH
-
-
-
-
?
3beta,20alpha-dihydroxypregn-5-ene + NADP+
3beta-hydroxypregn-5-en-20-one + NADPH
-
-
-
-
?
4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide + NADPH
hydroxyhexamide + NADP+
4-nitrobenzaldehyde + NADPH
?
-
-
-
-
?
4-pregnen-11beta,21-diol-3,20-dione + NADPH
4-pregnen-11beta,20alpha,21-triol-3-one + NADP+
-
-
-
-
?
5alpha-androstan-17beta-ol-3-one + NAD(P)H + H+
5alpha-androstan-3alpha,17beta-diol + NAD(P)+
5alpha-androstan-3alpha-ol-17-one + alpha-NAD+
5alpha-dihydrotestosterone + alpha-NADH + H+
-
-
-
-
r
5alpha-androstan-3alpha-ol-17-one + beta-NAD+
5alpha-dihydrotestosterone + beta-NADH + H+
-
-
-
-
r
5alpha-androstane-3,17-dione + NADPH
?
-
-
-
-
?
5alpha-dihydrotestosterone + alpha-NADH + H+
5alpha-androstan-3alpha-ol-17-one + alpha-NAD+
-
-
-
-
r
5alpha-dihydrotestosterone + alpha-NADPH + H+
5alpha-androstan-3alpha-ol-17-one + alpha-NADP+
-
-
-
-
r
5alpha-dihydrotestosterone + beta-NADH + H+
5alpha-androstan-3alpha-ol-17-one + beta-NAD+
-
-
-
-
r
5alpha-dihydrotestosterone + NADP+
5alpha-androstane-3,17-dione + NADPH + H+
-
-
-
-
?
5alpha-dihydrotestosterone + NADPH
5alpha-androstan-3alpha,17beta-diol + NAD+
-
-
-
?
5alpha-dihydrotestosterone + NADPH + H+
5alpha-androstan-3alpha,17beta-diol + NADP+
14.4% of the activity with p-nitrobenzaldehyde
-
-
?
5alpha-pregnane-3,20-dione + NADH
?
-
-
-
-
?
5alpha-pregnane-3,20-dione + NADPH
?
-
-
-
-
?
5beta-androstan-17beta-ol-3-one + NAD(P)H
?
-
i.e. 5beta-dihydrotestosterone
-
-
?
5beta-dihydrotestosterone + NADPH
5beta-androstan-3alpha,17beta-diol + NADP+
9.2% of the activity with p-nitrobenzaldehyde
-
-
?
6beta-(bromoacetoxy)-progesterone + NADH
?
-
-
-
-
?
6beta-[bromoacetoxy]-progesterone + NAD+
?
-
-
-
-
r
9,10-phenanthrenequinone + NADPH
?
-
-
-
-
?
androsterone + NAD+
? + NADH
camphorquinone + NADPH + H+
camphorquinol + NADP+
-
-
-
-
?
corticosterone + NADH + H+
? + NAD+
cortisone + NAD(P)H
17alpha,20beta,21-trihydroxy-pregn-4-ene-3,11-dione + NAD(P)+
cortisone + NADH + H+
20beta-hydroxycortisone + NAD+
cortisone + NADPH + H+
20beta-hydroxycortisone + NADP+
cyclohexanone + NADPH
cyclohexanol + NADP+
-
-
-
-
?
deoxycorticosterone + NADPH
20,21-dihydroxypregn-4-ene-3-one + NADP+
deoxycortisol + NADPH
?
-
-
-
-
?
epiandrosterone + NAD+
? + NADH
hydrindantin + NADPH
?
-
-
-
-
?
menadione + NADPH
?
75% of the activity with p-nitrobenzaldehyde
-
-
?
methylglyoxal + NADPH
?
-
-
-
-
?
p-nitrobenzaldehyde + NADPH
p-nitrobenzyl alcohol + NADP+
-
-
-
?
phenylglyoxal + NADPH
?
-
-
-
-
?
pregnenolone + NADPH
3beta,20beta-Dihydroxypregn-5-ene + NADP+
-
i.e. 3-hydroxypregn-5-en-20-one
-
-
?
progesterone + NAD(P)H
20beta-hydroxy-pregn-4-ene-3-one + NAD(P)+
progesterone + NADH
20beta-hydroxy-pregn-4-ene-3-one + NAD+
22% of the activity with androsterone
-
-
?
progesterone + NADP+
20beta-hydroxy-pregn-4-ene-3-one + NADPH + H+
-
-
-
-
?
progesterone + NADPH
20beta-hydroxy-pregn-4-ene-3-one + NADP+
tetrahydrocortisol + NADH + H+
? + NAD+
additional information
?
-
11-deoxycortisol + NADH + H+

? + NAD+
-
i.e. 4-pregnen-17,21-diol-3,20-dione, 49.8% of the activity compared to cortisone
-
-
?
11-deoxycortisol + NADH + H+
? + NAD+
-
i.e. 4-pregnen-17,21-diol-3,20-dione, 49.8% of the activity compared to cortisone
-
-
?
17alpha-hydroxy-3,20-dioxo-4-pregnen-21-oate + NADH

17,20alpha-dihydroxy-4-pregnen-3-one-21-oate + NAD+
-
-
-
-
?
17alpha-hydroxy-3,20-dioxo-4-pregnen-21-oate + NADH
17,20alpha-dihydroxy-4-pregnen-3-one-21-oate + NAD+
-
-
-
-
?
17alpha-hydroxy-3,20-dioxo-4-pregnen-21-oate + NADH
17,20alpha-dihydroxy-4-pregnen-3-one-21-oate + NAD+
-
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+

17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
-
maturation-inducing hormone of oocytes
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
4.3% of the activity with p-nitrobenzaldehyde
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
-
maturation-inducing hormone of oocytes
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
-
maturation-inducing hormone of oocytes
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
-
maturation-inducing hormone of oocytes
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
4.3% of the activity with p-nitrobenzaldehyde
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
20beta-hydroxysteroid dehydrogenase activity is reduced in diabetic rats
-
r
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-4-pregnene-3-one + NADP+
-
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+

17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
17alpha-hydroxyprogesterone reduction in non-flagellated germ cells and in spermatozoa
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
enzyme wild type A and B, mutants of enzyme type A and B
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
r
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
?
17alpha-hydroxyprogesterone + NADPH + H+
17alpha,20beta-dihydroxy-pregn-4-ene-3-one + NADP+
-
-
-
-
?
17beta-estradiol + NAD+

estrone + NADH + H+
4% of the activity with androsterone
-
-
?
17beta-estradiol + NAD+
estrone + NADH + H+
4% of the activity with androsterone
-
-
?
20alpha-hydroxyprogesterone + NAD+

? + NADH
2% of the activity with androsterone
-
-
?
20alpha-hydroxyprogesterone + NAD+
? + NADH
2% of the activity with androsterone
-
-
?
20beta-hydroxycortisone + NADH + H+

cortisone + NADH + H+
-
under in vitro conditions, the enzyme catalyzes reductive reaction far more readily than oxidative reaction
-
-
r
20beta-hydroxycortisone + NADH + H+
cortisone + NADH + H+
-
under in vitro conditions, the enzyme catalyzes reductive reaction far more readily than oxidative reaction
-
-
r
20beta-hydroxyprogesterone + NAD+

? + NADH
69% of the activity with androsterone
-
-
?
20beta-hydroxyprogesterone + NAD+
? + NADH
69% of the activity with androsterone
-
-
?
3,20-dioxo-4-pregnen-21-oic acid + NADH

20beta-hydroxy-3-oxo-4-pregnen-21-oic acid + NAD+
-
-
-
?
3,20-dioxo-4-pregnen-21-oic acid + NADH
20beta-hydroxy-3-oxo-4-pregnen-21-oic acid + NAD+
-
-
-
-
?
3alpha,20beta-hydroxysteroid androstanes or pregnane derivatives + NAD(P)H

?
-
enzyme belongs to the group of short-chain dehydrogenases
-
-
?
3alpha,20beta-hydroxysteroid androstanes or pregnane derivatives + NAD(P)H
?
-
enzyme belongs to the group of short-chain dehydrogenases
-
-
r
4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide + NADPH

hydroxyhexamide + NADP+
-
male-specific and androgen-dependent activity, competitive to progesterone, cortisone, cortisol and 17alpha-hydroxyprogestrone consumption
-
?
4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide + NADPH
hydroxyhexamide + NADP+
-
male-specific and androgen-dependent activity, competitive to progesterone, cortisone, cortisol and 17alpha-hydroxyprogestrone consumption
-
?
5alpha-androstan-17beta-ol-3-one + NAD(P)H + H+

5alpha-androstan-3alpha,17beta-diol + NAD(P)+
-
i.e. 5alpha-dihydrotestosterone
-
?
5alpha-androstan-17beta-ol-3-one + NAD(P)H + H+
5alpha-androstan-3alpha,17beta-diol + NAD(P)+
-
i.e. 5alpha-dihydrotestosterone
-
-
?
5alpha-androstan-17beta-ol-3-one + NAD(P)H + H+
5alpha-androstan-3alpha,17beta-diol + NAD(P)+
-
i.e. 5alpha-dihydrotestosterone
ratio 4:3
?
androsterone + NAD+

? + NADH
-
-
-
?
androsterone + NAD+
? + NADH
-
-
-
?
corticosterone + NADH + H+

? + NAD+
-
i.e. 4-pregnen-11beta,21-diol-3,20-dione, 39.8% of the activity compared to cortisone
-
-
?
corticosterone + NADH + H+
? + NAD+
-
i.e. 4-pregnen-11beta,21-diol-3,20-dione, 39.8% of the activity compared to cortisone
-
-
?
cortisone + NAD(P)H

17alpha,20beta,21-trihydroxy-pregn-4-ene-3,11-dione + NAD(P)+
-
-
-
-
?
cortisone + NAD(P)H
17alpha,20beta,21-trihydroxy-pregn-4-ene-3,11-dione + NAD(P)+
-
-
-
-
?
cortisone + NAD(P)H
17alpha,20beta,21-trihydroxy-pregn-4-ene-3,11-dione + NAD(P)+
-
i.e. 17beta,21-dihydroxy-pregn-4-ene-3,11,20-trione
-
?
cortisone + NAD(P)H
17alpha,20beta,21-trihydroxy-pregn-4-ene-3,11-dione + NAD(P)+
-
i.e. 17beta,21-dihydroxy-pregn-4-ene-3,11,20-trione
-
-
?
cortisone + NADH + H+

20beta-hydroxycortisone + NAD+
-
the equilibrium for the recombinant enzyme clearly favors the reductive direction. Cortisol is the preferred substrate, as it is more rapidly converted to 20beta-dihydrocortisol relative to other structurally similar steroids tested
-
-
r
cortisone + NADH + H+
20beta-hydroxycortisone + NAD+
-
the equilibrium for the recombinant enzyme clearly favors the reductive direction. Cortisol is the preferred substrate, as it is more rapidly converted to 20beta-dihydrocortisol relative to other structurally similar steroids tested
-
-
r
cortisone + NADPH + H+

20beta-hydroxycortisone + NADP+
-
-
i.e. 4-pregnen-17alpha,20beta,21-triol-3,11-dione
-
?
cortisone + NADPH + H+
20beta-hydroxycortisone + NADP+
-
no activity with NAD+
-
-
?
deoxycorticosterone + NADPH

20,21-dihydroxypregn-4-ene-3-one + NADP+
-
-
-
-
?
deoxycorticosterone + NADPH
20,21-dihydroxypregn-4-ene-3-one + NADP+
-
i.e. 21-hydroxypregn-4-ene-3,20-dione, 21-hydroxyprogesterone
-
-
?
epiandrosterone + NAD+

? + NADH
3% of the activity with androsterone
-
-
?
epiandrosterone + NAD+
? + NADH
3% of the activity with androsterone
-
-
?
progesterone + NAD(P)H

20beta-hydroxy-pregn-4-ene-3-one + NAD(P)+
-
-
-
?
progesterone + NAD(P)H
20beta-hydroxy-pregn-4-ene-3-one + NAD(P)+
-
-
-
r
progesterone + NAD(P)H
20beta-hydroxy-pregn-4-ene-3-one + NAD(P)+
-
-
-
?
progesterone + NAD(P)H
20beta-hydroxy-pregn-4-ene-3-one + NAD(P)+
-
-
-
-
?
progesterone + NAD(P)H
20beta-hydroxy-pregn-4-ene-3-one + NAD(P)+
-
-
-
-
?
progesterone + NADPH

20beta-hydroxy-pregn-4-ene-3-one + NADP+
2.5% of the activity with p-nitrobenzaldehyde
-
-
?
progesterone + NADPH
20beta-hydroxy-pregn-4-ene-3-one + NADP+
-
-
-
?
progesterone + NADPH
20beta-hydroxy-pregn-4-ene-3-one + NADP+
-
20beta-hydroxysteroid dehydrogenase activity is reduced in diabetic rats
-
r
progesterone + NADPH
20beta-hydroxy-pregn-4-ene-3-one + NADP+
-
-
-
-
?
tetrahydrocortisol + NADH + H+

? + NAD+
-
i.e. 5beta-pregnan-3alpha,11beta,17,21-tetrol-20-one, 49.2% of the activity compared to cortisone
-
-
?
tetrahydrocortisol + NADH + H+
? + NAD+
-
i.e. 5beta-pregnan-3alpha,11beta,17,21-tetrol-20-one, 49.2% of the activity compared to cortisone
-
-
?
additional information

?
-
-
catalyzes the oxidoreduction of a variety of steroid substrates, including the steroid antibiotic fusidic acid, catalyzes the interconversion of hydroxy and oxo groups at position 3 of the steroid ring structure, enzyme is capable of catalyzing the carbonyl reduction of non-steroidal xenobiotic carbonyl compounds, contributes to the bioremediation of natural and synthetic toxicants, plays a central role in steroid metabolism
-
-
?
additional information
?
-
-
constitutive enzyme
-
-
?
additional information
?
-
catalyzes the NADPH reduction of carbonyl compounds and steroids, steroidogenic enzyme, key enzyme for the production of maturation-induced steroid
-
-
?
additional information
?
-
the enzyme plays an important role in the meiotic maturation of tilapia gametes
-
-
?
additional information
?
-
-
the enzyme plays an important role in the meiotic maturation of tilapia gametes
-
-
?
additional information
?
-
-
enzyme cannot catalyze the reduction of 11-hydroxy- or 11-oxo-C21-steroids, i.e. cortisol, corticosterone, cortisone
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.